Dana Farber Cancer Institute Reg. Ped

Boston, Massachusetts 02215

0 studies enrolling now · 1 studies all time

What they study most

Hematologic Neoplasms

Studies at this site

• Study to Allow Access to Single Agent Panobinostat for Patients Who Are on s.a. Panobinostat Treatment in a Novartis-sponsored Study and Continue to Benefit From the Treatment as Judged by the Investigator — Completed